We are live on ! Find out more
QNRX

Quoin Pharmaceuticals
QNRX

1 hedge funds and large institutions have $345K invested in Quoin Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$494K

Top Sellers

No sellers this quarter

QNRX Hedge Fund Activity: Q3 2016 in Review

1 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q3 2016, worth a combined $345K.

Buyers outnumbered sellers: 1 fund opened new QNRX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $494K.

  • 1 institutional investor held Quoin Pharmaceuticals (QNRX) as of Q3 2016, up from 0 in Q2 2016.
  • Funds reported $345K of Quoin Pharmaceuticals stock for Q3 2016.
  • 1 fund opened new Quoin Pharmaceuticals positions in Q3 2016 and 0 closed out, a net change of +1 holder.
  • The largest Quoin Pharmaceuticals buyer in Q3 2016 was Sabby Management, an estimated $494K added.

Based on aggregated 13F filings for Q3 2016.